Searched for
IPCA LABORATORIES SHAREHOLDERS
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
PFC to trade ex-dividend from Monday. Last day to buy shares for eligibilityPower Finance Corporation (PFC) is approaching its ex-dividend date of November 25th, with a planned dividend payout of Rs 3.5 per share. I...
Last date to buy today! Grasim Industries among 12 stocks to trade ex-dividend on TuesdayToday is the last day to buy shares of Grasim Industries, Ipca Laboratories, and 10 other companies to qualify for dividends, with August 6...
Ipca Laboratories shareholders reject employees stock option scheme resolutionThe Employee Stock Option Scheme, being a special resolution, required at least 75 per cent votes in favour. Only 63.8 per cent of the vote...
Ipca bleeds as Street fears Unichem acquisition a likely earnings dragIpca on Monday announced the acquisition of Unichem by acquiring a 33.38% stake from the promoter at ₹1,034 crore. It will spend another ₹8...
Hold Ipca Laboratories, target price Rs 790: Sharekhan by BNP ParibasIpca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 17596.92 Crore) operating in Pharmaceutic...
Ipca Labs shares tumble 9% on acquisition of stake in Unichem LaboratoriesIpca Laboratories has agreed to buy 33.38% of the paid-up equity share capital of Unichem Laboratories for INR1,034.06 crore ($160m). The a...
Ipca Labs set to acquire Unichem promoter's stake for over ₹ 1,034 crThe Mumbai-based Ipca will also make an open offer to the public equity shareholders of Unichem to acquire from them upto 26% of the fully ...
Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 crore"The Board approved entering into a definitive Share Purchase Agreement (SPA) for the acquisition of 2,35,01,440 fully paid-up equity share...
Corporate Radar: Vedanta to consider dividend; PTC India results and moreVedanta has fixed November 30 as the record date to determine shareholders’ eligibility for the dividend. So far in FY23, the company has d...
Ipca Labs Q2 results: Net profit declines 6% to Rs 250 croreThe board has "approved subdivision of every 1 equity share of the nominal/face value of Rs 2/ each into 2 equity shares of the nominal/fac...
In process of obtaining environmental clearance for new plant in Madhya Pradesh: Ipca LabsSharing information with the company's shareholders, the drug maker said the company has already acquired land for the project.
Trending stocks: Ipca Laboratories share price down 1%Shares of traded 0.78 per cent down in trade at 10:58AM on Thursday .
Paytm Payments Bank appoints Sudhanshu Jain as CFOBorrowing (Foreign Currency) at ICICI Bank.He has also worked.
Shareholders’ approval must to reappoint MDs above 70The Bombay High Court recently ruled that a managing director and whole-time director who crossed 70 will be ‘automatically disqualified’.
Proxy advisory firms question promoters' disproportionately high salaries in companiesProxy advisory firms that provide advisory services to institutional shareholders on using their votes in companies, are questioning dispro...
Foreign investors can invest up to 40% in Somany CeramicsThe Reserve Bank has allowed foreign investors to invest up to 40 per cent of the paid-up capital in tiles maker Somany Ceramics.
Ipca Labs gains on plan to acquire 50% stake in Avik PharmaShares of Ipca Laboratories moved higher after the company entered into an agreement to acquire 50% stake in Avik Pharmaceuticals for 6.51 ...
Ipca Labs inks pact to acquire 50% stake in Avik PharmaIpca Laboratories said it has entered into an agreement with Avik Pharmaceutical Ltd to acquire 50 per cent stake in the firm.
- Ipca & Makers hike stake in Mangalam Drugs to 14%
Mumbai-based mid-size pharma company Ipca Laboratories along with Makers Laboratories has picked up additional stake in bulk drugs and chem...